Animated cartoon features the benefits of newborn screening for genetic diseases.
The Torion® T-9™, the first portable GC/MS, runs samples onsite and can test for contaminants in the environment, food and products.
Using TIBCO Spotfire® visualization tools, PerkinElmer demonstrates this analytical versatile software in the study of infectious diseases.
PerkinElmer-GIS Centre for Precision Oncology leverages genome expertise and leading edge imaging instrumentation to develop new cancer therapies.
Researchers at the University of Oklahoma have discovered potent polyphenols in brown seaweed that target and prevent the spread of pancreatic cancer cells. Their research is a potential blueprint for fighting the most lethal form of cancer, saving thousands of lives each year.
PerkinElmer, a global leader in life and environmental science, recently expanded its presence in Taiwan by opening a new Taipei customer service center.
Using a suite of PerkinElmer's analytical imaging instruments, Dementias Platform United Kingdom (DPUK) is taking a whole-body approach to early detection, better treatment, and prevention of neurodegenerative conditions including Parkinson’s Disease, Motor Neurone Diseases, Multiple Sclerosis, Huntington’s Disease, Creutzfeldt–Jakob Disease, and Alzheimer’s Disease.
Heavy metals such as lead, chromium, and mercury are being emitted into the air.
Choosing the right visual analytics platform can help companies achieve clinical operational excellence.
Genetic Screening Processor will speed testing of millions of babies for genetic disorders.